Activest Wealth Management’s Capricor Therapeutics CAPR Stock Holding History

Activest Wealth Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.2K	Hold	2,000	–	–	0.01%	285
2026 Q1	$60.8K	Hold	2,000	–	–	0.01%	300
2025 Q4	$57.7K	Sell	2,000 -3,000	-60%	-$39.2K	0.01%	298
2025 Q3	$36K	Hold	5,000	–	–	0.01%	296
2025 Q2	$49.6K	Hold	5,000	–	–	0.01%	212
2025 Q1	$47.5K	Hold	5,000	–	–	0.01%	199
2024 Q4	$69K	Hold	5,000	–	–	0.02%	147
2024 Q3	$76K	Sell	5,000 -5,000	-50%	-$24.7K	0.02%	143
2024 Q2	$47.7K	Buy	+10,000	New	+$55.8K	0.02%	171

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Activest Wealth Management's CAPR Position: Q2 2026 in Review

Activest Wealth Management held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 2,000 shares worth $48.2K. The position accounts for 0.01% of the portfolio, ranked #285.

Activest Wealth Management first reported a position in CAPR in Q2 2024 and has held it in 9 quarters since. The position peaked at $76K in Q3 2024. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Activest Wealth Management held 2,000 shares of Capricor Therapeutics worth $48.2K as of Q2 2026.
Activest Wealth Management left its Capricor Therapeutics share count unchanged in Q2 2026.
Capricor Therapeutics made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #285 holding.
Activest Wealth Management first reported a position in Capricor Therapeutics in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Capricor Therapeutics position peaked at $76K in Q3 2024.
169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.